WithdrawnNo phase
Registry for Pancreatic Cancer
Key facts
- Who runs it
- Duke University
- Where
- Durham, United StatesSee the 2 sites
- Trial code
- Status
- Withdrawn
- Started
- 4 May 2017
- Expected to end
- Apr 2037
- Type of study
- Observational
- Record updated
- 6 December 2017
- Why it stopped
- Study design changed to clinical database only with no research question to be studied.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Pancreatic cancer
Who cannot take part
- Younger than 18 years of age
Where in United States
- Duke University Health SystemDurham, United StatesNo longer taking part
- Duke University Medical CenterDurham, United StatesNo longer taking part
About the trial
What the trial wants to find out
This is an observational, prospective and retrospective registry of patients with pancreatic cancer treated in Duke University Health System, which will examine patient and treatment effects on cancer outcomes.
The group in the trial
- Patients with pancreatic cancer
Patients diagnosed with pancreatic cancer evaluated at this institution.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Registry to Evaluate Multi-modality Therapies for Pancreatic Cancer
- Record updated
- 6 December 2017